Skip to content
Open access

Tissue-specific untargeted 1H-NMR metabolomics reveals no adverse metabolic effects of daily intrabuccal cannabidiol (CBD) in healthy mice

Aug 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 41 references
Medicine

TL;DR

The results suggest a more metabolically balanced state in the mice, and support the adjunctive use of CBD, as no adverse metabolic effects were observed in the brain, liver, or kidneys.

Abstract

Background Cannabidiol (CBD) has attracted renewed scientific attention for its therapeutic potential in human metabolism. However, the metabolic effects of CBD treatment remain incompletely understood. Methods This study investigated tissue-specific metabolic alterations in the brain, liver, and kidneys of Kramnik mice after 2 weeks of daily CBD treatment using an untargeted proton magnetic resonance (1H-NMR) metabolomics approach. Results Unsupervised principal component analysis (PCA) revealed minimal biological variation between the CBD-treated and control groups. The most notable, albeit minor, changes were observed in the brain and were associated with decreased signaling and neuroenergetics. The liver showed changes in sugar metabolism, and the kidneys showed only minor changes in phenylalanine levels. Discussion Collectively, our results suggest a more metabolically balanced state in the mice. These data support the adjunctive use of CBD, as no adverse metabolic effects were observed in the brain, liver, or kidneys.

Read PDF

Similar papers

Open access Sep 2026

Untargeted LC-MS-Based Metabolomics Reveals Metabolic Fate and Cellular Biochemical Disruptions Induced by 4,4-Diaminodiphenylmethane in Human Skin Fibroblasts.

Human exposure to 4,4'-diaminodiphenylmethane (MDA) occurs predominantly through dermal contact, yet its extra-hepatic biotransformation pathways and the metabolomic disturbances it induces remain poorly characterized. In this study, human skin fibroblasts were incubated with MDA, and untargeted LC-HRMS metabolomics wa...

Radhika Kawathe, Andhela Leela Sairam, Sridhar Chinthakindi · 0 citations
Oct 2026

Evaluation of Acute Pharmacokinetics and Liver Metabolic Response of L -Se-Methylselenocysteine in Mice Using UPLC-QqQ-MS/MS and Untargeted Metabolomics

L-Se-methylselenocysteine (L-SeMC) is a natural organic selenium compound with potential nutritional applications, but its acute disposition and metabolic responses remain incompletely characterized. Here, UPLC-QqQ-MS/MS was used to characterize L-SeMC pharmacokinetics and tissue distribution in H22 tumor-bearing mic...

Hon-Gan Li, Xin-Ru Tang, Hui Liu et al. · 0 citations
Open access Aug 2026

Amino acid- and lipid-related metabolic remodeling in PTZ-kindled mice reveals candidate plasma signatures of chronic epilepsy

PTZ-induced kindling was associated with marked plasma metabolic alterations involving amino acid-, tryptophan-, and lipid-related pathways, which supports the broader relevance of metabolic dysregulation to epilepsy, while the mechanistic roles and biomarker potential of individual metabolites require independent vali...

Juan Ren, Fu-Li Wang, Zi-Jian Li et al. · 0 citations
Open access Sep 2026

Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.

Reliable endogenous biomarkers for assessing CYP3A activity and clinical drug-drug interaction (DDI) risk remain limited. We characterized global metabolomic changes following itraconazole treatment in a fixed-sequence DDI study (11 healthy volunteers) to identify novel CYP3A endogenous biomarkers. Untargeted metabolom...

S. Yee, Eugene P. Kadar, Matthew A. Cerny et al. · 0 citations
Aug 2026

Metabolomics-based elucidation of the regional difference mechanism of the PPARγ signaling axis in sheep hepatic cystic echinococcosis.

Cystic echinococcosis (CE) is a zoonotic parasitic disease caused by infection with Echinococcus granulosus sensu lato, with the liver being the primary affected organ. This study aimed to investigate the metabolic profile alterations and differential regulation of the PPARγ signaling axis in proximal and distal hepati...

Mutailipu Maimaiti, Mayire Aizezi, Weifan Gu et al. · 0 citations
Sep 2026

Integrated cell-mouse metabolomics reveals toxicity mechanisms and biomarkers of prothioconazole exposure.

BACKGROUND Prothioconazole (PTC) is one of the most widely used triazole fungicides worldwide, while its major metabolite, prothioconazole-desthio (dPTC), exhibits enhanced toxicological potential. However, the metabolic perturbations induced by chronic PTC exposure and sensitive biomarkers for exposure monitoring rema...

Lin-Lin Shi, Wen-Hui Li, Xian-Dan Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.